Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,227,515,506
+$494,345,233 QoQ
Shares Held
20,773,786
-4.5% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#11
of 4,138 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FMR LLC holds $75,393,052,380 across 17 Drug Manufacturers - General names. ABBV ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
28,462,475 | $34,138,749,234 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
66,870,816 | $8,448,458,890 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,440,355 | $5,839,085,616 | |
| 4 | JNJ |
Johnson & Johnson
|
22,595,566 | $5,738,595,894 | |
| 5 | AZN |
Astrazeneca PLC
|
28,895,264 | $5,479,119,956 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
20,773,786 | $5,227,515,506 | |
| 7 | BIIB |
Biogen Inc.
|
18,217,239 | $3,936,016,655 | |
| 8 | GSK |
GSK plc
|
64,961,641 | $3,405,289,219 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,227,515,506 | 20,773,786 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,733,170,273 | 21,762,703 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,166,019,288 | 22,609,389 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,870,464,041 | 21,035,087 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,898,320,146 | 21,001,617 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,952,336,658 | 23,636,582 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,215,903,535 | 18,097,375 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,691,732,179 | 13,630,404 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,250,159,555 | 13,118,934 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,274,137,090 | 12,488,397 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,718,714,463 | 11,090,627 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,680,125,614 | 11,271,472 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,468,507,146 | 10,899,630 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,053,559,900 | 12,885,486 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $2,321,284,585 | 14,363,496 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,015,728,977 | 15,019,216 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,666,849,793 | 17,412,182 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,016,250,107 | 18,606,194 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,310,362,693 | 17,063,240 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,331,790,621 | 21,616,674 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $3,993,873,998 | 35,456,978 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,967,756,758 | 36,663,803 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $3,113,151,313 | 29,054,142 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $2,650,226,306 | 30,257,179 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,079,917,790 | 31,370,114 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $2,667,130,680 | 35,006,309 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||